← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Bioceres Crop Solutions Corp. (BIOX) 10-Year Financial Performance & Capital Metrics

BIOX • • Industrial / General
Basic MaterialsAgricultural InputsCrop Protection & ChemicalsSpecialty Chemical & Biologicals
AboutBioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.Show more
  • Revenue $333M -28.3%
  • EBITDA $14M -79.3%
  • Net Income -$52M -1697.3%
  • EPS (Diluted) -0.82 -1704.7%
  • Gross Margin 39.06%
  • EBITDA Margin 4.11% -71.1%
  • Operating Margin -1.11% -111.5%
  • Net Margin -15.54% -2327.5%
  • ROE -16.02% -1784.4%
  • ROIC -0.5% -108.3%
  • Debt/Equity 0.94 +21.5%
  • Interest Coverage -0.07 -104.4%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 14.1%
  • ✓Trading at only 0.3x book value

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Weak momentum: RS Rating 4 (bottom 4%)
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y14.1%
3Y0.49%
TTM-28.27%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-1672.56%

EPS CAGR

10Y-
5Y-
3Y-
TTM-1962.59%

ROCE

10Y Avg14.04%
5Y Avg11.18%
3Y Avg7.04%
Latest-0.78%

Peer Comparison

Specialty Chemical & Biologicals
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
SMGThe Scotts Miracle-Gro Company3.72B64.1125.96-3.93%4.26%7.37%
BIOXBioceres Crop Solutions Corp.84.43M1.33-1.62-28.3%-15.3%-17.28%41.81%0.94

Profit & Loss

Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Sales/Revenue+93.71M133.49M160.31M172.35M206.7M328.46M419.45M464.83M333.3M
Revenue Growth %-0.42%0.2%0.08%0.2%0.59%0.28%0.11%-0.28%
Cost of Goods Sold+59.86M77.09M86.68M92.86M115.82M202.02M239.2M283.24M203.1M
COGS % of Revenue0.64%0.58%0.54%0.54%0.56%0.62%0.57%0.61%0.61%
Gross Profit+33.85M56.4M73.62M79.49M90.88M126.44M180.25M181.59M130.2M
Gross Margin %0.36%0.42%0.46%0.46%0.44%0.38%0.43%0.39%0.39%
Gross Profit Growth %-0.67%0.31%0.08%0.14%0.39%0.43%0.01%-0.28%
Operating Expenses+41.32M38.55M41.83M41.32M49.97M84.91M111.76M136.77M133.9M
OpEx % of Revenue0.44%0.29%0.26%0.24%0.24%0.26%0.27%0.29%0.4%
Selling, General & Admin27.39M35.26M30.84M29.48M44.39M57.36M85.54M94.27M139.5M
SG&A % of Revenue0.29%0.26%0.19%0.17%0.21%0.17%0.2%0.2%0.42%
Research & Development3.98M3.95M3.69M4.2M5.62M6.95M15.35M17.18M0
R&D % of Revenue0.04%0.03%0.02%0.02%0.03%0.02%0.04%0.04%-
Other Operating Expenses0007.65M-34.25K20.6M10.87M25.32M-5.6M
Operating Income+-706.92K15.71M32.09M39.15M38.38M39.87M54.18M44.82M-3.7M
Operating Margin %-0.01%0.12%0.2%0.23%0.19%0.12%0.13%0.1%-0.01%
Operating Income Growth %-23.22%1.04%0.22%-0.02%0.04%0.36%-0.17%-1.08%
EBITDA+3.9M20.08M36.91M43.88M44.65M49.06M73.57M66.12M13.69M
EBITDA Margin %0.04%0.15%0.23%0.25%0.22%0.15%0.18%0.14%0.04%
EBITDA Growth %-4.15%0.84%0.19%0.02%0.1%0.5%-0.1%-0.79%
D&A (Non-Cash Add-back)4.61M4.37M4.83M4.73M6.26M9.19M19.39M21.3M17.39M
EBIT-706.92K-12.77K12.46M25.84M37.44M38.73M52.99M34.16M-3.8M
Net Interest Income+00-44.34M-11.66M-21.24M-17.93M-23.79M-26.87M-50.1M
Interest Income14.92M01.49M7.73M00000
Interest Expense0021.84M19.4M21.24M17.93M23.79M26.87M50.1M
Other Income/Expense-21.68M-40.95M-41.46M0-27.85M-25.81M-35.08M-34.78M-50.2M
Pretax Income+-22.39M-25.24M-9.37M6.44M10.53M14.06M19.11M10.04M-53.9M
Pretax Margin %-0.24%-0.19%-0.06%0.04%0.05%0.04%0.05%0.02%-0.16%
Income Tax+-5.63M-10.93M6.99M2.21M14.35M17.97M-1.07M3.78M1.3M
Effective Tax Rate %0.53%0.44%1.96%0.52%-0.65%-0.51%0.98%0.32%0.96%
Net Income+-11.82M-11.04M-18.37M3.36M-6.87M-7.2M18.78M3.24M-51.8M
Net Margin %-0.13%-0.08%-0.11%0.02%-0.03%-0.02%0.04%0.01%-0.16%
Net Income Growth %-0.07%-0.66%1.18%-3.05%-0.05%3.61%-0.83%-16.97%
Net Income (Continuing)-16.76M-14.31M-16.36M1.76M-3.82M-3.91M20.17M6.26M-55.2M
Discontinued Operations000000000
Minority Interest41.4M19.42M14.79M14.57M22.55M30.68M31.65M36.08M32.41M
EPS (Diluted)+-0.42-0.39-0.600.09-0.18-0.170.300.05-0.82
EPS Growth %-0.07%-0.54%1.15%-2.95%0.06%2.76%-0.83%-17.05%
EPS (Basic)-0.42-0.39-0.600.09-0.18-0.170.300.05-0.82
Diluted Shares Outstanding28.1M28.1M30.48M36.42M39.22M42.3M63.19M63.48M63.2M
Basic Shares Outstanding28.1M28.1M30.48M36.12M39.22M42.3M62.15M62.84M63.2M
Dividend Payout Ratio---------

Balance Sheet

Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Total Current Assets+87.77M85.34M98.21M164.69M211.49M297.71M397.11M408.67M308.31M
Cash & Short-Term Investments1.68M2.23M3.81M55.96M46.78M38.61M60.05M56.17M34.74M
Cash Only1.68M2.22M3.45M27.16M36.05M33.48M48.13M44.47M32.7M
Short-Term Investments4.28K12.53K356.23K28.8M10.74M5.14M11.92M11.7M2.04M
Accounts Receivable41.68M52.89M59.24M77.84M99.15M128.08M185.32M216.03M177.75M
Days Sales Outstanding162.33144.61134.87164.85175.08142.33161.26169.64194.66
Inventory31.34M19.37M27.59M30.77M63.35M126.1M140.57M126.22M89.99M
Days Inventory Outstanding191.0991.69116.18120.93199.66227.84214.51162.66161.72
Other Current Assets12.8M10.86M7.36M128.65K425.98K265.12K212.7K00
Total Non-Current Assets+152.1M111.3M144.26M132.87M183.1M220.52M420.94M443.88M455.33M
Property, Plant & Equipment46.22M40.18M43.83M42.63M49.28M62.05M81.79M86.18M90.95M
Fixed Asset Turnover2.03x3.32x3.66x4.04x4.19x5.29x5.13x5.39x3.66x
Goodwill25.08M14.44M29.8M25.53M28.75M36.07M112.16M112.16M112.16M
Intangible Assets42.06M26.66M39.62M35.33M67.34M76.7M173.78M176.89M181.17M
Long-Term Investments32.88M19.32M25.7M26.35M31.75M39.17M39.74M40.42M39.37M
Other Non-Current Assets5.87M5.11M1.56M334.73K2.69M2.5M6.15M18.53M26.76M
Total Assets+239.87M196.64M242.47M297.56M394.59M518.22M818.06M852.55M763.65M
Asset Turnover0.39x0.68x0.66x0.58x0.52x0.63x0.51x0.55x0.44x
Asset Growth %--0.18%0.23%0.23%0.33%0.31%0.58%0.04%-0.1%
Total Current Liabilities+69.39M118.68M116.46M130.61M168.04M222.67M298.71M329.31M337.99M
Accounts Payable22.28M26.08M38.66M54.79M69.31M124.41M146.29M161.93M91.58M
Days Payables Outstanding135.86123.48162.78215.37218.42224.77223.23208.67164.58
Short-Term Debt33.57M65.03M66.09M64.39M76.79M71.3M107.64M136.75M222M
Deferred Revenue (Current)01000K1000K1000K1000K1000K1000K1000K1000K
Other Current Liabilities7.65M22.84M4.49M2.5M2.79M10.67M5.93M11.96M7.94M
Current Ratio1.26x0.72x0.84x1.26x1.26x1.34x1.33x1.24x0.91x
Quick Ratio0.81x0.56x0.61x1.03x0.88x0.77x0.86x0.86x0.65x
Cash Conversion Cycle217.56112.8188.2770.41156.33145.39152.54123.63191.81
Total Non-Current Liabilities+90.74M44.82M63.91M106.9M136.26M137.26M188.85M171.86M130.44M
Long-Term Debt40.27M25.25M36.62M84.96M96.65M86.74M135.88M122.91M38.2M
Capital Lease Obligations678.99K454.26K462.87K444.71K390.41K10.34M10.03M8.16M9.53M
Deferred Tax Liabilities013.59M21.1M16.86M25.7M29.01M35.79M35M30.12M
Other Non-Current Liabilities49.79M19.12M26.83M4.64M13.52M11.18M5.09M3.86M51.15M
Total Liabilities160.13M163.51M180.37M237.51M304.3M359.92M487.56M501.17M468.43M
Total Debt+74.99M91.02M103.56M149.79M174.58M169.79M257.41M270.95M276.61M
Net Debt73.31M88.8M100.11M122.63M138.53M136.31M209.28M226.47M243.91M
Debt / Equity0.94x2.75x1.67x2.49x1.93x1.07x0.78x0.77x0.94x
Debt / EBITDA19.23x4.53x2.81x3.41x3.91x3.46x3.50x4.10x20.20x
Net Debt / EBITDA18.80x4.42x2.71x2.79x3.10x2.78x2.84x3.43x17.81x
Interest Coverage--1.47x2.02x1.81x2.22x2.28x1.67x-0.07x
Total Equity+79.74M33.13M62.09M60.05M90.29M158.3M330.5M351.38M295.22M
Equity Growth %--0.58%0.87%-0.03%0.5%0.75%1.09%0.06%-0.16%
Book Value per Share2.841.182.041.652.303.745.235.534.67
Total Shareholders' Equity38.34M13.71M47.3M45.48M67.74M127.61M298.85M315.3M262.81M
Common Stock2.81K2.81K3.61K3.61K4.16K4.64K6.49K6.5K6.5K
Retained Earnings-15.11M-26.15M-21.97M-18.61M-25.48M-32.68M-13.9M-9.63M-65.04M
Treasury Stock000-30.91K-4.45M-3.53M-30.55M-31.29M-32.21M
Accumulated OCI-5.31M-28.27M-27.22M-32.37M-27.37M1.98M1.12M633.49K91.81K
Minority Interest41.4M19.42M14.79M14.57M22.55M30.68M31.65M36.08M32.41M

Cash Flow

Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Cash from Operations+19.1M18.39M29.69M9.32M-6.21M-17.52M2.59M41.72M49.91M
Operating CF Margin %0.2%0.14%0.19%0.05%-0.03%-0.05%0.01%0.09%0.15%
Operating CF Growth %--0.04%0.62%-0.69%-1.67%-1.82%1.15%15.11%0.2%
Net Income-11.82M-14.31M-16.36M4.24M-3.82M-3.91M20.17M6.26M-58.85M
Depreciation & Amortization4.61M4.37M4.83M4.73M6.26M9.19M19.39M21.3M22.18M
Stock-Based Compensation51.42K30K-102.83K3.43M1.66M1.43M3.42M14.13M4.39M
Deferred Taxes0-10.93M6.99M2.21M14.35M17.97M-1.07M3.78M1.27M
Other Non-Cash Items-15.24M47.32M45.79M33.51M29.23M18.65M45.78M37.76M61.61M
Working Capital Changes41.51M-8.09M-11.44M-38.8M-53.88M-60.85M-85.11M-41.51M19.3M
Change in Receivables33.49M17.32M41.49M-21.74M1.99M-24.97M-56.87M-51.65M24.58M
Change in Inventory-2.25M10.36M-8.64M-5.31M-34.5M-55.31M-11.07M14.18M34.91M
Change in Payables0-35.29M-33.7M8.27M-5.83M53.48M-4.5M14.23M0
Cash from Investing+-20.16M-8.22M-3.26M-7.8M-8.31M2.9M-25.73M-28.73M-6.13M
Capital Expenditures-1.39M-5.71M-3.45M-4.5M-13.92M-9M-22.56M-9.79M-5.64M
CapEx % of Revenue0.01%0.04%0.02%0.03%0.07%0.03%0.05%0.02%0.02%
Acquisitions---------
Investments---------
Other Investing-18.77M-2.51M317.95K0309.81K5.12M137.36K-12.66M-8.57M
Cash from Financing+2.33M-10.46M-26.95M33.53M7.36M14.82M32.95M-10.06M-50.71M
Debt Issued (Net)---------
Equity Issued (Net)---------
Dividends Paid000000000
Share Repurchases---------
Other Financing2.33M-578.29K-4.55M2.3M-18.81M-13.91M-23.27M-27.65M-22.21M
Net Change in Cash---------
Free Cash Flow+17.71M12.68M26.25M4.82M-20.13M-26.51M-19.97M18.93M35.3M
FCF Margin %0.19%0.09%0.16%0.03%-0.1%-0.08%-0.05%0.04%0.11%
FCF Growth %--0.28%1.07%-0.82%-5.18%-0.32%0.25%1.95%0.86%
FCF per Share0.630.450.860.13-0.51-0.63-0.320.300.56
FCF Conversion (FCF/Net Income)-1.62x-1.67x-1.62x2.77x0.90x2.43x0.14x12.86x-0.96x
Interest Paid000000000
Taxes Paid000000000

Key Ratios

Metric201720182019202020212022202320242025
Return on Equity (ROE)-14.82%-19.56%-38.58%5.5%-9.14%-5.79%7.68%0.95%-16.02%
Return on Invested Capital (ROIC)-0.35%8.57%16.94%17.03%13.99%11.43%9.74%6.02%-0.5%
Gross Margin36.12%42.25%45.93%46.12%43.97%38.49%42.97%39.07%39.06%
Net Margin-12.61%-8.27%-11.46%1.95%-3.32%-2.19%4.48%0.7%-15.54%
Debt / Equity0.94x2.75x1.67x2.49x1.93x1.07x0.78x0.77x0.94x
Interest Coverage--1.47x2.02x1.81x2.22x2.28x1.67x-0.07x
FCF Conversion-1.62x-1.67x-1.62x2.77x0.90x2.43x0.14x12.86x-0.96x
Revenue Growth-42.46%20.09%7.51%19.93%58.91%27.7%10.82%-28.3%

Revenue by Geography

201920202021202220242025
Argentina---261.62M346.79M231.55M
Argentina Growth----32.55%-33.23%
North America----27.37M30.11M
North America Growth-----10.00%
Brazil---33.05M24.18M17.67M
Brazil Growth-----26.85%-26.89%
Europe, Middle East and Africa----21.32M7.92M
Europe, Middle East and Africa Growth------62.85%
France---9.79M--
France Growth------
Uruguay---8.06M--
Uruguay Growth------
Paraguay---6.85M--
Paraguay Growth------
United States of America---5.09M--
United States of America Growth------
South Africa---3.13M--
South Africa Growth------
the world---435.09K--
the world Growth------
Bolivia---430.23K--
Bolivia Growth------
U4.68M6.23M5.75M---
U Growth-33.09%-7.73%---
P2.51M4.43M5.37M---
P Growth-76.67%21.27%---
Z3.02M1.93M2.79M---
Z Growth--36.17%44.72%---
Rest Of World1.32M215.5K360.52K---
Rest Of World Growth--83.62%67.30%---
C-319.68K----
C Growth------
I-188.6K----
I Growth------
G137.04K123.84K----
G Growth--9.63%----
Italia132.21K-----
Italia Growth------

Frequently Asked Questions

Growth & Financials

Bioceres Crop Solutions Corp. (BIOX) reported $333.4M in revenue for fiscal year 2025. This represents a 256% increase from $93.7M in 2017.

Bioceres Crop Solutions Corp. (BIOX) saw revenue decline by 28.3% over the past year.

Bioceres Crop Solutions Corp. (BIOX) reported a net loss of $51.0M for fiscal year 2025.

Dividend & Returns

Bioceres Crop Solutions Corp. (BIOX) has a return on equity (ROE) of -16.0%. Negative ROE indicates the company is unprofitable.

Bioceres Crop Solutions Corp. (BIOX) generated $28.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.